IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 25 September 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01028-06v1
74/12/7024    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossmann, E.
Right arrow Articles by Wallich, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossmann, E.
Right arrow Articles by Wallich, R.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01028-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

BbCRASP-1 of the Lyme disease spirochetes is expressed in humans and induces antibody responses restricted to non-denatured structural determinants

Evelyn Rossmann, Veronique Kitiratschky, Heidelore Hofmann, Peter Kraiczy, Markus M. Simon, and Reinhard Wallich*

Department of Immunology, University of Heidelberg, Heidelberg, Germany; University Clinics for Dermatology and Allergology "Am Biederstein", TU München, Germany; Institute of Medical Microbiology, University Hospital of Frankfurt, Frankfurt, Germany; Metschnikoff Laboratory, Max-Planck-Institute for Immunobiology, Freiburg, Germany

* To whom correspondence should be addressed. Email: wallich{at}uni-hd.de.


   Abstract

BbCRASP-1, the dominant factor H and FHL-1 binding protein of the Lyme disease spirochete Borrelia burgdorferi is implied in pathogen persistence and was recently reported to be non-immunogenic in man. Here we show that serum samples from Lyme disease patients contain antibodies with exclusive specificity for non-denatured structural determinants of BbCRASP-1.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.